SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
momo-T/FIF
An SI Board Since October 2003
Posts SubjectMarks Bans
12215 138 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11090Cara Therapeutics common stock offering of $80 M, with up to $12M additional undD.Lu-3/29/2017
11089"lazy ideological fools"..... Lamar Smith et al.scaram(o)uche-3/29/2017
11088Thanks Rick for my press release! And thanks to tuck and Miljenko for the nice Biotech Jim33/29/2017
11087FWIW, the CMO did throw in a tidbit about the oral OA trial: that they were not tuck-3/28/2017
11086To be bit more clear (from my perspective), after initial Jim comment I had smalMiljenko Zuanic-3/28/2017
11085What are two things that Alexander Granach and Sean Spicer have in common?? 1. scaram(o)uche-3/28/2017
11084That's a question for the entire oral program, IMO. Given the much lower bituck-3/28/2017
11083I wold also like to her opinions why 0.5 mg dose fired the best (small # trial).Miljenko Zuanic-3/28/2017
11082Typo in post is that 05.mg/kg should be 0.5mg/kg. Doh! Cheers, Tucktuck-3/28/2017
11081Indeed, Jim was and is exceptional contributor for many years!Miljenko Zuanic-3/28/2017
11080CARA call: yup, second the big hat tip to BJ. My CC notes here: CARA UP data Ctuck-3/28/2017
11079"Sufficient receptor occupancy"?? Sounds familiar...... Message 3056scaram(o)uche13/28/2017
11078CARA: no dose response, but plasma concentrations at all doses yield sufficienttuck-3/28/2017
11077CARA: Obviously, nice to see good p values, but given that there were three dosetuck-3/28/2017
11076Wenstrup believes that FBI should give him guidance re. ethics, rather than the scaram(o)uche-3/20/2017
11075If I could stop time, what would I do? Would I select the default, and loiter iscaram(o)uche-3/20/2017
11074This Gowdy jackass is hilarious.scaram(o)uche-3/20/2017
11073I think you pointed at Sanguin as a CAR-T competitor, but even with search, I catuck-3/16/2017
11072Isn't 010 the only candidate outside cancer (immunology/autoimmune)? I thinMiljenko Zuanic-3/13/2017
11071MGNX . . . It looks as though the most imminent catalyst is some datatuck-3/13/2017
11070RE: RDUS Why bios can not do business without "Fucxxxx around"?Miljenko Zuanic-3/10/2017
11069Sold TGTX at $11.25. Sold more MGNX puts. Wondering if the market is finally btuck-3/7/2017
11068<I don't expect anyone to go out and dig up answers, particularly you, JiBiotech Jim-3/7/2017
11067>> No repeat dosing in humans yet that I'm aware of << Thanks!scaram(o)uche-3/7/2017
11066Thanks for posting Nigel. I had missed that. Here's some background and a A.J. Mullen-3/7/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News